Equivital solutions for the pharmaceutical & medical device industry provide technology and services for the acquisition, management and analysis of real world, subjective and objective, human data.

In an increasingly competitive market, solutions tailored to study program and therapeutic area  can reduce time to market, cost of R&D and improve pipeline productivity.

Real World Human Data

Real world human data refers to subject orientated data captured without interference or bias from the environment and methodology of the data collection itself.

Including real world human data through the product development lifecycle can accelerate the time to reimbursement, reduce cost, drive efficiency and improve recruitment & retention of subjects.

Equivital provides technology and services that enable subjective and objective data to be collected in both pre and post market studies. The types of data include physiological, patient reported, clinician rated outcomes and environmental data, to support reporting of safety and effectiveness.

Safety and Efficacy

Bigger, more accurate, contextualised datasets provide for better profiling of drug effects and adverse events. Continuous monitoring from Equivital enables study monitors to reach out to patients swiftly to respond to adverse events. Controlled access to data throughout your study allows for adaptive designs, improving productivity and protocol compliance.


Equivital technology and services are modular & scalable, ensuring a “perfect fit” to your study aims, budget and protocol requirements.

We provide real world human data acquisition and management systems for single site early phase trials to solutions for global, multi site centralised studies.

We also offer supporting services including protocol advice, data analysis and innovation development, (biomarkers and companion diagnostics).


Click here to download the Orann Brochure and the Orann Case Study


For further information please contact the Equivital Clinical Trials Team